Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
Advances in Therapy|August 24, 2023
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical TrialDaniel Q Huang, Veeral Ajmera, Christian Tomaszewski, et al.
Alimentary Pharmacology & Therapeutics|March 26, 2026
Systematic Review: Imaging-Based Morphological Criteria for Liver Cirrhosis-A Call to StandardiseMei Chin Lim, Ethan Joo Wei Quek, Talia Yi Hui Chan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 28, 2023
The incidence of adverse outcome in donors after living donor liver transplantation: A meta-analysis of 60,829 donorsJieling Xiao, Rebecca Wenling Zeng, Wen Hui Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 29, 2023
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 StudiesKai En Chan, Elden Yen Hng Ong, Charlotte Hui Chung, et al.
Diabetes, Obesity & Metabolism|May 23, 2024
The prognostic value of metabolic dysfunction-associated steatotic liver disease in acute myocardial infarction: A propensity score-matched analysisGwyneth Kong, Grace Cao, Jaycie Koh, et al.
Nature Reviews. Gastroenterology & Hepatology|September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver diseaseLuis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2021
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysisMichael H Le, Yee Hui Yeo, Xiaohe Li, et al.
Hepatology (Baltimore, Md.)|October 18, 2024
Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction-associated steatotic liver diseaseMonica A Tincopa, Luis Antonio Díaz, Daniel Q Huang, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2025
Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Kaleb Tesfai, Luis Antonio Díaz, Juan Pablo Arab, et al.
Gut|July 25, 2023
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysisElina En Li Cho, Chong Zhe Ang, Jingxuan Quek, et al.
Pageof 23